Abstract
A new study calls for further investigation into the potential benefits and risks of COX-2 specific inhibitors (pages 698-701).
| Original language | English |
|---|---|
| Pages (from-to) | 621-622 |
| Number of pages | 2 |
| Journal | Nature medicine |
| Volume | 5 |
| Issue number | 6 |
| DOIs | |
| State | Published - Jun 1999 |